AC Immune SA (ACIU) Earnings Date & Reports

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ACIU is expected to report earnings to fall 171.21% to 9 cents per share on July 30

AC Immune SA ACIU Stock Earnings Reports

Q2'26

Est.

$0.10

Q4'25

Beat

by $0.02

Q3'25

Beat

by $0.03

Q2'25

Missed

by $0.04

Q1'25

Beat

by $0.01

The last earnings report on March 13 showed earnings per share of -14 cents, beating the estimate of -15 cents. With 58.70K shares outstanding, the current market capitalization sits at 227.46M.

View a ticker or compare two or three

Compare

ACIU

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ACIU